微创心通-B盘中涨超9% 微创心通TAVI核心产品在摩洛哥获批上市

Core Viewpoint - MicroPort CardioFlow-B (02160) has seen a significant increase in stock price, with a rise of over 9% during trading, currently up 6.06% at HKD 1.05, with a trading volume of HKD 4.48 million [1] Group 1: Product Approval and Market Expansion - MicroPort CardioFlow's VitaFlow Liberty aortic valve and retrievable system has been approved for sale in Morocco, marking its entry into the African market [1] - The Moroccan medical device market is highly reliant on imported products, and this approval lays the groundwork for further expansion into other African countries [1] Group 2: Corporate Developments - On December 19, MicroPort Medical announced the completion of the acquisition of Cardiac Rhythm, which will enhance the integration of its structural heart disease and cardiac rhythm management business segments [1] - The latest integration plan indicates that MicroPort Medical will accelerate the development of a comprehensive device management solution covering all causes, stages, and processes of heart failure [1]